Claude Gardin
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 87
- Chronic Myeloid Leukemia Treatments 22
- Multiple Myeloma Research and Treatments 20
- Hematopoietic Stem Cell Transplantation 19
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 22
- Chronic Lymphocytic Leukemia Research 15
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 18
- Oncology top 5%
-
- Acute Lymphoblastic Leukemia research 25
- Co-authors
- Hervé DombretPierre FenauxEmmanuel RaffouxSylvie CastaignéCécile PautasXavier ThomasLionel AdèsChristine Terré
- Cited by
- HematologyGeneticsMolecular Biology
- Partner nations
- FranceItalyUnited States
In The Last Decade
Claude Gardin
117 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 3.2k
- Genetics 1.1k
- Molecular Biology 1.9k
- Oncology 750
- Public Health, Environmental and Occupational Health 800
Countries citing papers authored by Claude Gardin
This map shows the geographic impact of Claude Gardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Gardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Gardin more than expected).
Fields of papers citing papers by Claude Gardin
This network shows the impact of papers produced by Claude Gardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Gardin. The network helps show where Claude Gardin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claude Gardin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 0 | |
| 6 | 2020 | 8 | |
| 7 | 2018 | 3 | |
| 8 | 2018 | 21 | |
| 9 | 2016 | 36 | |
| 10 | 2016 | 21 | |
| 11 | 2011 | 16 | |
| 12 | 2010 | 16 | |
| 13 | 2009 | 43 | |
| 14 | 2008 | 227 | |
| 15 | 2008 | 107 | |
| 16 | 2006 | 226 | |
| 17 | 2006 | 72 | |
| 18 | 2000 | 19 | |
| 19 | 1997 | 56 | |
| 20 | 1997 | 26 |
About Claude Gardin
Claude Gardin is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 123 papers that have together received 4.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (87 papers), Acute Lymphoblastic Leukemia research (25 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Chronic Myeloid Leukemia Treatments (22 papers), Multiple Myeloma Research and Treatments (20 papers), Hematopoietic Stem Cell Transplantation (19 papers), Histone Deacetylase Inhibitors Research (18 papers) and Chronic Lymphocytic Leukemia Research (15 papers). The work is most often cited by research in Hematology (3.2k citations), Genetics (1.1k citations) and Molecular Biology (1.9k citations). Claude Gardin has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Hervé Dombret, Pierre Fenaux, Emmanuel Raffoux, Sylvie Castaigné, Cécile Pautas, Xavier Thomas, Lionel Adès, Christine Terré, Pascal Turlure and Claude Preudhomme. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.